Microcrystalline Cellulose companies

Companies Dominating the Microcrystalline Cellulose Market

Microcrystalline cellulose is a highly competitive market, with strong demand for innovation and safety.  The global market for MCC is dominated by DuPont (USA) and DFE Pharma (Germany), who has approximately 30% of the market share and also supply pharmaceutical grade MCC with RD capabilities. Asian competitors like Sigachi (India) and Mingtai (China) are also growing quickly, with lower cost manufacturing and government support.

Some of the key players operating in the market are listed below:

Company Name	Country	Market Share (2024)
DuPont de Nemours, Inc.	USA	19%
DFE Pharma	Germany	13%
JRS Pharma	Germany	11%
Asahi Kasei Corporation	Japan	10%
Mingtai Chemical Co., Ltd.	China	9%
Sigachi Industries Ltd.	India	xx%
Accent Microcell Pvt. Ltd.	India	xx%
Roquette Frères	France	xx%
Huzhou Zhanwang Pharmaceutical Co.	China	xx%
Wei Ming Pharmaceutical Manufacturing	Malaysia	xx%
FMC Corporation	USA	xx%
Avantor Performance Materials	USA	xx%
Anhui Sunhere Pharmaceutical	China	xx%
Pharmatrans-Sanaq AG	Switzerland	xx%

Here are a few areas of focus covered in the competitive landscape of the microcrystalline cellulose market:

• Company Overview
• Business Strategy
• Key Product Offerings
• Financial Performance
• Key Performance Indicators
• Risk Analysis
• Recent Development
• Regional Presence
• SWOT Analysis